Laura E. Niklason
President, CEO and Director, Director · Humacyte, Inc.
- 2024
- Jun 12, 2026
- 6
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Laura E. Niklason files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Kathleen Sebelius - $50K in HUMA purchases and sales in the last 12 months
- Dale A. Sander - $41K in HUMA purchases and sales in the last 12 months
- Shamik J. Parikh - $41K in HUMA purchases and sales in the last 12 months
- Keith Anthony Jones - $30K in HUMA purchases and sales in the last 12 months
- Michael T. Constantino - $10K in HUMA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Laura E. Niklason?
Laura E. Niklason is a corporate insider, tracked as President, CEO and Director, Director of Humacyte, Inc. (HUMA). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Laura E. Niklason last file a Form 4?
The most recent primary Form 4 on record is dated 12 June 2026, one of 6 filings going back to 2024.
Has Laura E. Niklason been buying or selling stock?
Recorded transactions: 1 open-market purchase ($8K) and 6 open-market sales ($10.34M) across all tracked filings.
